Literature DB >> 17713660

Low expression of antigen-presenting and costimulatory molecules by lung cells from tuberculosis patients.

V C S Flores-Batista1, N Boechat, P M Lago, L C Lazzarini, L R Pessanha, A S Almeida, T T Mafort, A L Kritski, J L Ho, J R Lapa-e-Silva.   

Abstract

Costimulatory and antigen-presenting molecules are essential to the initiation of T cell immunity to mycobacteria. The present study analyzed by immunocytochemistry, using monoclonal antibodies and alkaline phosphatase-anti-alkaline phosphatase method, the frequency of costimulatory (CD86, CD40, CD40L, CD28, and CD152) and antigen-presenting (MHC class II and CD1) molecules expression on human lung cells recovered by sputum induction from tuberculosis (TB) patients (N = 22) and non-TB controls (N = 17). TB cases showed a statistically significant lower percentage of HLA-DR+ cells than control subjects (21.9 +/- 4.2 vs 50.0 +/- 7.2%, P < 0.001), even though similar proportions of TB cases (18/22) and control subjects (16/17, P = 0.36) had HLA-DR-positive-stained cells. In addition, fewer TB cases (10/22) compared to control subjects (16/17) possessed CD86-expressing cells (P = 0.04; OR: 0.05; 95%CI = 0.00-0.51), and TB cases expressed a lower percentage of CD86+ cells (P = 0.04). Moreover, TB patients with clinically limited disease ( pound1 lobe) on chest X-ray exhibited a lower percentage of CD86-bearing cells compared to patients with more extensive lung disease (>1 lobe) (P = 0.02). The lower expression by lung cells from TB patients of HLA-DR and CD86, molecules involved in antigen presentation and activation of T cells, may minimize T cell recognition of Mycobacterium tuberculosis, fostering an immune dysfunctional state and active TB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17713660     DOI: 10.1590/s0100-879x2006005000141

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  2 in total

1.  Mycobacteria exploit p38 signaling to affect CD1 expression and lipid antigen presentation by human dendritic cells.

Authors:  Maria Cristina Gagliardi; Raffaela Teloni; Federico Giannoni; Sabrina Mariotti; Maria Elena Remoli; Valeria Sargentini; Melissa Videtta; Manuela Pardini; Gennaro De Libero; Eliana Marina Coccia; Roberto Nisini
Journal:  Infect Immun       Date:  2009-08-31       Impact factor: 3.441

2.  Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis.

Authors:  Paola Del Carmen Guerra-De-Blas; Miriam Bobadilla-Del-Valle; Isabel Sada-Ovalle; Iris Estrada-García; Pedro Torres-González; Alejandro López-Saavedra; Silvia Guzmán-Beltrán; Alfredo Ponce-de-León; José Sifuentes-Osornio
Journal:  Front Microbiol       Date:  2019-09-20       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.